Robin Peter, PhD

This educational session will address why dosimetry is central to modern radiopharmaceutical therapy. It will highlight how fixed-activity approaches emerged historically and why they are increasingly insufficient in the context of therapeutic precision, safe...

Open-source radiotherapy quality assurance (OSQA) tools are increasingly available and offer potential value in resource-constrained settings. However, clinical adoption remains limited by gaps in validation, standardization, and implementation guidance, rath...

Radiopharmaceutical therapy (RPT) is re-shaping how radiation is used to combat cancer since it provides a way to deliver radiation systemically. Due to its impactful clinical applications, RPT has been approved by the FDA to treat patients with metastatic ca...

Translation of tissue and tumor dose-response thresholds from external-beam radiation therapy (EBRT) to radiopharmaceutical therapies (RPTs) for dose optimization requires accurate values of relative biological effectiveness (RBE), which are still not known p...